Skin autofluorescence test for advanced sugars in rheumatic diseases
Part of Bones, joints & muscles, Genetic & congenital, Immune system & allergy, Infections, Skin clinical trials.
This study uses a non-invasive light test on the skin to measure advanced sugars (AGEs) that build up in rheumatic diseases. It compares people with inflammatory rheumatic conditions to healthy volunteers to see if this test helps understand disease activity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You have a confirmed inflammatory rheumatic disease (like rheumatoid arthritis, psoriatic arthritis, or Behçet disease) or you are a healthy volunteer without such conditions.
- You do not have diabetes (type 1 or type 2).
- You do not have chronic kidney disease with low kidney function.
- You have no active cancer or history of cancer in the last 5 years, no current infection, and no pregnancy or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who are at high risk for developing rheumatoid arthritis, as well as first-degree relatives of RA patients and people with very early untreated RA. It aims to learn more about the disease so doctors can better predict and prevent it.
This trial looks at a blood marker called FAP to see if it relates to fibrosis (tissue scarring) in people with rheumatoid arthritis or systemic sclerosis. It may help understand how the disease affects the body.
This study is for people with certain rheumatic conditions (like arthritis, lupus, or vasculitis) and for healthy volunteers. It aims to learn more about these diseases and improve how they are treated.
This study checks if the medicine sulfasalazine affects a blood sugar test (HbA1c) in people with inflammatory arthritis. If you have arthritis, take sulfasalazine, and have higher blood sugar or diabetes, this trial may help understand your glucose levels.
This study looks at how inflammatory “cytokines” are expressed in people with psoriasis—both those with joint involvement and those without. It may help researchers understand what drives joint disease and guide better future monitoring or treatments.
This study uses a blood test called mass spectrometry to look at the immune system in people with active autoimmune diseases. It aims to find patterns that could help doctors better understand and treat these conditions.
Hear when a new Ankylosing Spondylitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.